- Leading institutional investors commit $95 million through a common stock private investment in public equity (“PIPE”) led by Foresite Capital, as well as Fidelity Management & Research Company LLC, ...
Gemini Therapeutics, a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular degeneration (AMD), today announced the completion of its ...
FS Development, a blank check company formed by Foresite Capital targeting a healthcare business, filed on Friday with the SEC to raise up to $100 million in an initial public offering. The San ...
Who is FS Development Holdings, LLC? FS Development Holdings, LLC has an estimated net worth of $150 Million. This is based on reported shares in FS Development Corp..
LOS ANGELES, May 16, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm is investigating FS Development Corp relating to its proposed merger with Gemini Therapeutics (GMTX). Please visit our website to ...
Copyright 2020 FactSet Research Systems Inc. All rights reserved. Source: FactSet Fundamentals Stocks: Real-time U.S. stock quotes reflect trades reported through ...
CAMBRIDGE, Mass. & SAN FRANCISCO--(BUSINESS WIRE)--Gemini Therapeutics, a clinical stage precision medicine company developing innovative treatments for genetically defined age-related macular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results